DIMA SUKI to Interferon-gamma
This is a "connection" page, showing publications DIMA SUKI has written about Interferon-gamma.
Connection Strength
0.014
-
A prospective crossover randomized trial of novobiocin and rifampin prophylaxis for the prevention of intravascular catheter infections in cancer patients treated with interleukin-2. Cancer. 1998 Jan 15; 82(2):403-11.
Score: 0.014